Photodynamic therapy using photosensitizers as therapeutic agents has various advantages such as high antitumor efficacy, spatiotemporal selectivity, and noninvasiveness. However, photosensitizers also accumulate in normal tissues as well as tumor tissues, causing side effects. Here, we report chlorophyll‒peptide conjugates as novel photosensitizers to decrease the side effect. The assembled conjugates are expected to exhibit tumor-selective accumulation and tumor-selective activation of phototoxicity.
- Miyu Nagatani
- Masaru Yoshikawa
- Shogo Matsubara
